A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma
Clinical trial NCT00874614 · UNKNOWN
Trial details
- NCT number
- NCT00874614
- Sponsor
- Molecular Insight Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-04
- Primary completion
- 2017-02-14
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.